Nephrol Dial Transplant (2002) 17: 1085-1092
© 2002 European Renal Association-European Dialysis and Transplant Association
Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival
Department of Nephrology, North Staffordshire Hospital Trust, Stoke-on-Trent, UK
Background. Comorbidity is the single most important determinant of outcome in patients on renal replacement therapy. The aims of this study were to evaluate a semi-quantitative approach to comorbidity scoring in predicting survival of patients commencing peritoneal dialysis (PD), and to establish the interaction between this and other known predictors of patient outcome, in particular membrane function, residual renal function (RRF) and plasma albumin.
Methods. Comorbidity was recorded in a prospective, single centre cohort study of 303 patients commencing on PD. Using seven disease domains, chosen to reflect the dominance of cardiovascular morbidity in the end-stage renal failure population, comorbidity was graded as ‘0’ when absent, ‘1’ when one or two, and ‘2’ when three or more conditions were present. The Wright comorbidity index, which includes age within the scoring method, was also evaluated. RRF, plasma albumin and peritoneal solute transport were measured every 6 months. Patients were censored at death.
Results. Median survival according to grade of comorbidity was 105, 42 and 29 months, respectively (P<0.0001), with good separation of the actuarial survival curves. Using Cox regression, the addition of age and the grade of comorbidity to Kt/Vurea, solute transport and plasma albumin increased the predictive power of the model. All were independent predictors of outcome with the exception of albumin. The Wright comorbidity index also enhanced the Cox model, although was not as powerful as when age and comorbidity were considered independently. At baseline, RRF was not different according to comorbidity unless diabetes was considered separately. Diabetics started with higher RRF, but after 6 months on PD this was the same as non-diabetic patients. Otherwise, initial rate of decline of RRF was similar across the comorbid grades, although the impact of higher drop-out due to earlier loss in patients with more comorbidity may have disguised earlier loss in these patients. Peritoneal solute transport tended to be higher in patients with increased comorbidity at baseline, 
2 13.8, P=0.032, and this was sustained with time on treatment.
Conclusion. Comorbidity has a quantitative effect on survival that is independent of age, RRF and membrane function in PD patients. Comorbidity also appears to be associated with increased solute transport at the start of treatment, which is sustained. With the exception of diabetes, grade of comorbidity does not have a profound effect on loss of RRF.
Keywords: age; diabetes mellitus; ischaemic heart disease; left ventricular dysfunction; peripheral vascular disease; residual renal function; solute transport; Stoke PD Study
Correspondence and offprint requests to: Dr S. J. Davies, Department of Nephrology, North Staffordshire Hospitals Trust, Princes Road, Hartshill, Stoke-on-Trent ST4 7LN, UK. Email: SimonDavies1{at}compuserve.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Perl, K. Huckvale, M. Chellar, B. John, and S. J. Davies Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis Patients Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Guo, J. J. Carrero, X. Yu, P. Barany, A. R. Qureshi, M. Eriksson, B. Anderstam, M. Chmielewski, O. Heimburger, P. Stenvinkel, et al. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients Nephrol. Dial. Transplant., June 26, 2009; (2009) gfp315v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Carrero, X. Hua, P. Stenvinkel, A. R. Qureshi, O. Heimburger, P. Barany, B. Lindholm, and J. Frostegard Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis Nephrol. Dial. Transplant., June 23, 2009; (2009) gfp309v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ellam, M. El-Kossi, K.C. Prasanth, M. El-Nahas, and A. Khwaja Conservatively managed patients with stage 5 chronic kidney disease--outcomes from a single center experience QJM, June 17, 2009; (2009) hcp068v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Park, D. K. Kim, T. I. Chang, H. W. Kim, J. H. Chang, S. Y. Park, E. Kim, S.-W. Kang, D.-S. Han, and T.-H. Yoo Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients Nephrol. Dial. Transplant., June 2, 2009; (2009) gfp272v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Perl and J. M. Bargman PREDIALYSIS INTERVENTIONS FOR POSTDIALYSIS OUTCOMES Perit. Dial. Int., May 1, 2009; 29(3): 270 - 273. [Full Text] [PDF]
|
|
|
|
|
|
N. Prasad, A. Gupta, A. Sinha, A. Singh, R. K. Sharma, and A. Kaul IMPACT OF STRATIFICATION OF COMORBIDITIES ON NUTRITION INDICES AND SURVIVAL IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S153 - S157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Hwang, M.-J. Son, J. Yang, K. Kim, W. Chung, K.-W. Joo, Y. Kim, C. Ahn, and K.-H. Oh EFFECTS OF INTERLEUKIN-6 T15A SINGLE NUCLEOTIDE POLYMORPHISM ON BASELINE PERITONEAL SOLUTE TRANSPORT RATE IN INCIDENT PERITONEAL DIALYSIS PATIENTS Perit. Dial. Int., January 1, 2009; 29(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vychytil, C. Remon, C. Michel, P. Williams, A. Rodriguez-Carmona, B. Marron, E. Vonesh, S. van der Heyden, J. C. D. Filho, and on behalf of the Extraneal Peritonitis Study Group Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3711 - 3719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Oh, J.-Y. Moon, J. Oh, S. G. Kim, Y.-H. Hwang, S. Kim, J. S. Lee, and C. Ahn Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2356 - 2364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.E. Suliman, A.R. Qureshi, J.J. Carrero, P. Barany, M.I. Yilmaz, S. Snaedal-Jonsdottir, A. Alvestrand, O. Heimburger, B. Lindholm, and P. Stenvinkel The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality QJM, May 1, 2008; 101(5): 397 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Wiggins, S. P. McDonald, F. G. Brown, J. B. Rosman, and D. W. Johnson High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3005 - 3012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tomson, U. Udayaraj, J. Gilg, and D. Ansell Comorbidities in UK patients at the start of renal replacement therapy (Chapter 6) Nephrol. Dial. Transplant., August 1, 2007; 22(suppl_7): vii58 - vii68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. M. Murtagh, J. E. Marsh, P. Donohoe, N. J. Ekbal, N. S. Sheerin, and F. E. Harris Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1955 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Carrero, A. R. Qureshi, J. Axelsson, C. M. Avesani, M. E Suliman, S. Kato, P. Barany, S. Snaedal-Jonsdottir, A. Alvestrand, O. Heimburger, et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite Am. J. Clinical Nutrition, March 1, 2007; 85(3): 695 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. van Manen, P. C. W. van Dijk, V. S. Stel, F. W. Dekker, M. Cleries, F. Conte, T. Feest, R. Kramar, T. Leivestad, J. D. Briggs, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy Nephrol. Dial. Transplant., January 1, 2007; 22(1): 187 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Brimble, M. Walker, P. J. Margetts, K. K. Kundhal, and C. G. Rabbat Meta-Analysis: Peritoneal Membrane Transport, Mortality, and Technique Failure in Peritoneal Dialysis J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2591 - 2598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. J. den Elzen, J. G. van Manen, E. W. Boeschoten, R. T. Krediet, and F. W. Dekker The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1588 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. de Jonge, B. Bammens, W. Lemahieu, B. D. Maes, and Y. Vanrenterghem Comparison of peritoneal dialysis and haemodialysis after renal transplant failure Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1669 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Caravaca, M. V. Martin, S. Barroso, B. Ruiz, and R. Hernandez-Gallego Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients? Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1575 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Geddes, P. C. W. van Dijk, S. McArthur, W. Metcalfe, K. J. Jager, A. H. Zwinderman, M. Mooney, J. G. Fox, and K. Simpson The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy Nephrol. Dial. Transplant., April 1, 2006; 21(4): 945 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Clerbaux, J. Francart, P. Wallemacq, A. Robert, and E. Goffin Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1032 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Rodrigues, M. Almeida, I. Fonseca, M. Martins, M. J. Carvalho, F. Silva, C. Correia, M. J. Santos, and A. Cabrita Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation Nephrol. Dial. Transplant., March 1, 2006; 21(3): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rumpsfeld, S. P. McDonald, and D. W. Johnson Higher Peritoneal Transport Status Is Associated with Higher Mortality and Technique Failure in the Australian and New Zealand Peritoneal Dialysis Patient Populations J. Am. Soc. Nephrol., January 1, 2006; 17(1): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bammens, P. Evenepoel, K. Verbeke, and Y. Vanrenterghem Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1536 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Birmele, M. Francois, J. Pengloan, P. Francais, D. Testou, G. Brillet, D. Lechapois, S. Baudin, O. Grezard, J.-L. Jourdan, et al. Death after withdrawal from dialysis: the most common cause of death in a French dialysis population Nephrol. Dial. Transplant., March 1, 2004; 19(3): 686 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Miskulin, A. A. Martin, R. Brown, N. E. Fink, J. Coresh, N. R. Powe, P. G. Zager, K. B. Meyer, and A. S. Levey Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments Nephrol. Dial. Transplant., February 1, 2004; 19(2): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Brown, S. J. Davies, P. Rutherford, F. Meeus, M. Borras, W. Riegel, J. C. Divino Filho, E. Vonesh, and M. Van Bree Survival of Functionally Anuric Patients on Automated Peritoneal Dialysis: The European APD Outcome Study J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2948 - 2957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Chung, B. Lindholm, and H. B. Lee Is malnutrition an independent predictor of mortality in peritoneal dialysis patients? Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2134 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. van Manen, J. C. Korevaar, F. W. Dekker, E. W. Boeschoten, P. M. M. Bossuyt, and R. T. Krediet Adjustment for Comorbidity in Studies on Health Status in ESRD Patients: Which Comorbidity Index to Use? J. Am. Soc. Nephrol., February 1, 2003; 14(2): 478 - 485. [Abstract] [Full Text] [PDF]
|
|